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Protein ubiquitination has emerged as a pivotal regulatory
reaction that promotes cellular responses toDNAdamage.With
a goal todelineate theDNAdamage signal transduction cascade,
we systematically analyzed the human E2 ubiquitin- and ubiq-
uitin-like-conjugating enzymes for their ability to mobilize the
DNA damage marker 53BP1 onto ionizing radiation-induced
DNA double strand breaks. An RNAi-based screen identified
UBE2U as a candidate regulator of chromatin responses at dou-
ble strand breaks. Further mining of the UBE2U interactome
uncovered its cognate E3 RNF17 as a novel factor that, via the
radiosensitivity, immunodeficiency, dysmorphic features, and
learning difficulties (RIDDLE) syndrome protein RNF168,
enforces DNA damage responses. Our screen allowed us to
uncover new players in the mammalian DNA damage response
and highlights the instrumental roles of ubiquitin machineries
in promoting cell responses to genotoxic stress.
Radiosensitivity, immunodeficiency, dysmorphic features,
and learning difficulties (RIDDLE)4 syndrome is an immunode-
ficiency and radiosensitivity disorder that is manifested by, at
cellular levels, hypersensitivity to ionizing radiation, cell cycle
checkpoint abnormalities, and impaired end joining in the
recombined switch regions (1). Mutations in the E3 ubiquitin
ligase RNF168 were identified as the culprit responsible for the
cellular deficits observed in RIDDLE cells (2) and suggested
that RNF168 may play an important role in mounting cellular
responses to DNA damage. Indeed, RNF168 has emerged as a
core intermediate in the ubiquitin-driven DSB signal transduc-
tion cascade. By depositing ubiquitin adducts onto DSB-flank-
ing chromatin domains, RNF168 assembles DSB response pro-
teins, including 53BP1, BRCA1, and RAD18 (2–4), to drive
DNA damage responses (DDRs). Accordingly, RNF168-null
mice exhibit immunodeficiency, increased radiosensitivity, and
impaired spermatogenesis, highlighting pivotal roles of the E3
ubiquitin ligase in DSB responses and organismal development
(5).
Cell exposure to ionizing radiation (IR) triggers the phos-
phorylation of the histone variant H2AX (also known as
H2AX) (6), a histone mark that initiates a cascade of signaling
events at the local chromatin to mobilize DSB response pro-
teins into punctate structures commonly referred to as IR-in-
duced foci (IRIF) (7). Among the expanding list of DSB
response proteins that concentrate at the damaged chromatin,
RNF168 occupancy at IRIF requires its ability to recognize
ubiquitin adducts, a property attributable to its ubiquitin bind-
ingmotifs that display preference for different ubiquitin species
(2, 3, 8, 9). The ability of RNF168 to dock at DSBs also underlies
its key role in propagating ubiquitin-mediated DSB signals (2,
3) as mutations that inactivate either its ubiquitin binding
motifs or its E3 ubiquitin ligase activity impairedDNAdamage-
induced ubiquitylation and compromised retention of 53BP1
and BRCA1 at DSBs (2, 3, 10). Although the molecular basis
for the RNF168-dependent recruitment of BRCA1 onto DSBs
remains to be defined, RNF168 catalyzes H2A ubiquitination at
Lys13/15 (11), a biochemical reaction regulated by a conserved
acidic patch distal to lysine residues on the H2A/H2B surface
(12, 13), to effectively dock 53BP1 at DSBs (14, 15).
Intriguingly, the observations that DSBs are decorated by
Lys63-based ubiquitin species (16) and that depletion of either
RNF168 or UBC13 suppressed Lys63-ub at IRIF led to the orig-
inal proposal that RNF168 may pair with the E2 ubiquitin-con-
jugating enzyme UBC13 to catalyze Lys63-ub reactions (2, 3),
although subsequent studies suggested otherwise (11, 17–21).
Thus, given the dynamic nature of DSB-associated ubiquityla-
tion (22), together with the complexity of ubiquitin topologies
at play (19, 23–26), the identities and roles of each of the human
ubiquitin machineries in shaping the ubiquitin landscape at
DSBs remain to be defined. To this end, we used an RNA inter-
ference (RNAi)-based approach designed to target ubiquitin
and ubiquitin-like E2 enzymes and have uncovered UBE2U as a
new E2 enzyme important in driving DDRs. Further analysis of
E3-E2 interaction networks led to the identification of the
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RNF17-UBE2U pair as a novel module that promotes DSB sig-
nal transduction via the RIDDLE syndrome protein RNF168.
Results
RNAi Screen Identifies UBE2U as a Novel Regulator of 53BP1
Accumulation at DSBs—Ubiquitylation entails a cascade of
ATP-driven reactions that involve an E1 ubiquitin-activating
enzyme, an E2 ubiquitin-conjugating enzyme, and an E3 ubiq-
uitin ligase. By pairing with their E3 partners, E2 enzymes not
only serve “ubiquitin carrier” functions but also determine the
topology and length of ubiquitin chains, which in turn control
the ultimate fate of its substrates (27). Among the dozens of
human E2s, UBC13 encodes the only known Lys63-ub promot-
ing activity and is arguably the most studied ubiquitin-conju-
gating enzyme in the DDR network (28). Indeed, UBC13 plays
established roles in propagating ubiquitin signals to assemble
53BP1 andBRCA1 atDSBs (29–32). Given the critically impor-
tant roles of regulatory ubiquitylation in DSB signal transduc-
tion and repair processes (33), we were compelled to define the
ubiquitylating activities in the DDR network. Because the
human genome encodes only a few dozens of E2 ubiquitin- and
ubiquitin-like-conjugating enzymes and given the availability
of E2-E3 interacting protein networks (34–36), we reasoned
that a primary screen tailored to target E2 enzymes may allow
us to more efficiently isolate E2-E3 pairs as modules that regu-
late cellular responses to DNA damage.
We took advantage of the fact that IR treatment mobilizes
DNA damage mediator protein 53BP1 into discernable focal
structures, which would allow us to readily single out E2 candi-
dates for further in-depth study.Weused anRNAi approach for
this purpose. We targeted each E2 candidate using a pool of
four siRNAs and assessed IR-induced 53BP1 focus formation in
U2OS cells 48 h following siRNA transfection (Fig. 1A). In sup-
port of the validity of the screen, a number of E2 enzymes with
reported roles in the DSB signal transduction pathway were
identified, including UBC13 (29–32), UBC9 (37, 38), RAD6A
(20), and UBE2D2 (39) (Fig. 1B). Notably, our screen also led to
the identification of UBE2U as a candidate regulator of mam-
malian DDRs.
UBE2U Is Required for DSB Accumulation of DNA Damage
Mediator Proteins—UBE2U encodes a largely uncharacterized
E2 ubiquitin-conjugating enzyme and is composed of a typical
UBC domain at its N terminus (40) with an extension at its C
terminus (Fig. 2A). Cancer-derived UBE2Umutations, many of
which target its catalytic domain, have been catalogued (cBio-
Portal). We deconvoluted the pooled siRNAs and found that
two independent UBE2U-targeting siRNAs suppressed expres-
sion of HA-tagged UBE2U as determined by Western blotting
analysis (Fig. 2B). More importantly, resembling those de-
pleted of UBC13, cells pretreated with the two UBE2U
siRNAs also showed a substantial reduction of 53BP1 IRIF
(Fig. 2C). Our attempt to detect endogenous UBE2U was not
successful, although our rabbit polyclonal anti-UBE2U anti-
bodies that were raised against GST-UBE2U fusion proteins
as well as those from a commercial source (Novus catalogue
number H00148581-B01) specifically recognized overex-
pressed UBE2U (Fig. 2B).
Given the positive roles of UBE2U in supporting IR-induced
53BP1 focus formation, we tested whether UBE2Umight regu-
late the DSB accumulation of other DDR proteins, including
MDC1, RNF8, RNF168, and BRCA1. Interestingly, although
UBE2U depletion compromised BRCA1 and RNF168 IRIF for-
mation (Fig. 2,D and F), knockdown of UBE2U had nomeasur-
able effect on the ability of MDC1 or RNF8 to relocalize to
IR-induced DSBs (Fig. 2E), suggesting that UBE2U operates in
the canonical H2AX-dependent DSB signal transduction path-
way and that itmay regulate chromatin responses atDSBs at the
RNF168 level (Fig. 2G).
To explore the role of UBE2U in DNA damage responses, we
further examined its requirement in checkpoint control follow-
ing cell exposure to IR. We found that UBE2U-depleted cells,
much like those depleted of UBC13, failed to properly arrest at
the G2/M checkpoint following IR challenge (Fig. 3, A and B).

































































































































































































FIGURE 1. RNAi screen identifies novel E2 players in the DDR. A and B, HeLa cells transfected with non-targeting siRNAs (siCTR), pooled siRNAs designed to
target each of the human E2s (see Table 1), or those that targeted RNF8 (siRNF8) were irradiated (10 Gy). 4 h post-IR treatment, cells were fixed, permeabilized,
and immunostained with antibodies against 53BP1 and H2AX. Representative images are shown for cells depleted of RNF8 or UBC13 (siUBC13; A), and the
number of 53BP1 foci per cell was quantified and plotted (B). Data represent themean of two independent experiments, and at least 200 nuclei were counted
each time. Error bars represent S.D. n.s., no significance; *, p 0.05 versus control (CTR) cells.
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responses at the RNF168 level (Fig. 2G) and that UBE2U deple-
tion led to marked reduction in RNF168 expression (Figs. 2F
and 3C), we reasoned that if UBE2U enforces DNA damage
responses solely via RNF168 then the partial reduction in
RNF168 protein level in UBE2U-silenced cells should correlate
with milder phenotypic deficits when compared with RNF168
deficiency. To this end, we inactivatedRNF168 orUBE2Uusing
the RNAi approach (Fig. 3C), evaluated cell sensitivity to IR
using the clonogenic survival assay, and assessed the integrity of
the G2/M checkpoint bymeasuring cell arrest at the G2/M bor-
der following exposure to IR-induced DNA damage. Intrigu-
ingly, although RNF168-depleted cells were much more sensi-
tive to IR treatment (Fig. 2D), UBE2U silencing consistently
impaired the G2/M checkpoint to greater extents than that in
RNF168 knockdown cells (Fig. 2E). Together, these lines of
evidence suggest that UBE2U may promote DNA damage
responses via both RNF168-dependent and RNF168-indepen-
dent pathways.
RNAi-based Screen of UBE2U-binding E3s Identifies New
Regulators of DSB Responses—E2 ubiquitin-conjugating
enzymes pair with E3 ubiquitin ligases to confer substrate spec-
ificity. To better understand howUBE2U participates in DDRs,
we set out to identify UBE2U-interacting E3 partners. We took
advantage of the fact that previous E2-E3 interaction studies
have identified a total of 65 putative E3 partners of UBE2U (Fig.
4A) (34–36). To systematically examine whether any of these
E3s may participate in DSB responses, we again designed a


















































































FIGURE 2. UBE2U is a novel factor in DNA damage responses. A, schematic illustration of UBE2U protein domain organization and cancer-associated
mutations on the UBE2U coding sequence (adapted from cBioPortal). B, Western blotting analysis of RNAi-mediated UBE2U silencing. Cells were transfected
with control siRNAs (siCTR) or UBE2U-specific siRNAs either separately (siUBE2U-1 and siUBE2U-2) or as a pool (siUBE2U-mix) together with an expression
construct that encodesHA-UBE2U. 48 h post-transfection, cells were lysed, and proteinswere subjected to SDS-PAGE andWestern blotting experiments using
the indicated antibodies. Asterisk denotes non-specific bands. C andD, UBE2U is required for 53BP1 and BRCA1 IRIF. U2OS cells pretreatedwith two individual
UBE2U-specific siRNAswere irradiated andprocessed for immunostainingexperiments. Cellswere labeledwith antibodies against 53BP1or BRCA1andH2AX
as a DSBmarker. siRNA-mediated depletion of UBC13was used as positive control. E, UBE2U is not required forMDC1 or RNF8 IRIF. U2OS cells transfectedwith
siRNAs that targetedUBE2U (siUBE2U-1 and siUBE2U-2), RNF8 (siRNF8), or non-targeting siRNAs (siCTR) were irradiated (10Gy). 4 h post-IR treatment, cells were
fixed, permeabilized, and immunostained with antibodies against MDC1 and RNF8. Nuclei were visualized with DAPI. F, UBE2U promotes RNF168 IRIF. U2OS
cells pretreated with siRNAs that targeted UBE2U or RNF168 (siRNF168) were processed essentially as in E. G, schematic depicting the canonical DSB signal
transduction pathway where UBE2Umay play a role at the RNF168 level (see text). The percentage of cells positive for IRIF is shown and represents the mean
from at least two independent experiments (see “Experimental Procedures”).
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assessed whether any of the E3s may also be required for IR-
induced 53BP1 foci. We scored the percentage of 53BP1 focus-
positive cells following IR treatment and analyzed the z score
for each RNAi event as described previously (32) (Fig. 4B).
Interestingly, this approach led to the identification of a num-
ber of candidates that were required for 53BP1 IRIF formation,
including RNF17, TRIM34, TRIM65, and RNF10 (Fig. 4C). As a
control, inactivation of RNF168 resulted in marked reduction
of 53BP1 IRIF (Fig. 4C).
E3 Ubiquitin Ligase RNF17 Is Required for DSB Accumula-
tion of 53BP1 and BRCA1—We performed a thorough litera-
ture search and found that none of the E3 ubiquitin ligases have
documented roles in DDRs. Assuming that the E3s promoted
53BP1 in concerted efforts with UBE2U, one would expect that
silencing of the candidate E3s may phenocopy UBE2U inacti-
vation (Fig. 5A). Given the possible link between RNF17 and
RNF168 (see below), we decided to experimentally test whether
RNF17 also promotes DSB responses. Having confirmed the
RNF17-UBE2U interaction (Fig. 5B), we irradiated U2OS cells
following siRNA-mediated depletion of RNF17 and examined
whether the E3 ubiquitin ligase is required for docking of DSB
response factors at DNA breaks. Reminiscent to those seen in
UBE2U-depleted cells, RNF17 inactivation did not noticeably
affect DNA damage-induced focal accumulation of MDC1 and
RNF8 (Fig. 5C). Notably, not only was RNF17 required for
RNF168 IRIF (Fig. 5D) but inactivation of RNF17 compromised
53BP1, BRCA1, and ubiquitin conjugate accumulation at DSBs
(Fig. 5, E–G). Altogether, we concluded that RNF17 promotes
DSB ubiquitylation and enforces DSB accumulation of 53BP1
and BRCA1.
E3 Ubiquitin Ligase RNF17 Regulates mRNA Level of
RNF168—Having established an important role of RNF17 in
facilitating DSB accumulation of tumor suppressors 53BP1 and
BRCA1, we set out to explore the underlying mechanism.
RNF17 is a very large protein with 1623 amino acids and con-
sists of an N-terminal RING finger motif and five Tudor
domains that are distributed along the length of the protein
(Fig. 6A). RNF17 was originally identified in mouse as Mmip-2
(Mad member-interacting protein-2) where it interacts with
transcriptional repressorMad family proteins and regulates the
transcriptional activity of c-Myc (41, 42). Intriguingly, RNF17
inactivation by gene targeting resulted in a complete arrest in
round spermatids, indicating a key role of RNF17 in regulating
spermiogenesis (43). More importantly, a recent study showed
that mouse RNF17 might be involved in the PIWI-interacting
RNA (piRNA) pathway andmay post-transcriptionally regulate
expression of a cohort of genes, including RNF168 (44).
Our observations that the cellular deficits arising from
RNF17 depletion closely resembled those in RIDDLE cells are
in support of the idea that RNF17 plays integral roles in the
H2AX-dependentDSB signal transduction pathway by regulat-
ing RNF168 expression (see “Discussion”). Prompted by this
possibility, we further tested whether RNF17 knockdown may
affect RNF168 expression by Western blotting analysis. Our
effort in detecting endogenous RNF17 was hampered by the
lack of good antibodies either from a commercial source (Fig. 6,
A and B) or those that were raised against bacterially expressed
and purified RNF17 protein fragments (Fig. 6, A and C).
Regardless, we found that RNAi-mediated depletion of UBE2U
orRNF17 led tomarked reduction of RNF168proteins (Fig. 6,D
and E) but did not affect RNF8, an upstream E3 ubiquitin ligase
in the DSB signal transduction pathway. This lends credence to
the idea that UBE2U and RNF17 specifically regulate RNF168.
To test whether UBE2U or RNF17 promotes RNF168 gene
expression, we next quantified the RNF168 mRNA expression
level by real time PCR. Intriguingly, UBE2U and RNF17 deple-
tion reproducibly resulted in marked reduction in the RNF168
mRNA level (Fig. 6F). Taken together, we speculate that
UBE2U and/or RNF17 promotes RNF168 gene expression at
themRNA level, which in turn enforces functions of RNF168 in
DDRs.
To further explore whether roles of UBE2U or RNF17 in
regulatingDDRs are effected via RNF168, we undertook a func-
tional bypass approach to experimentally examine whether
reduction of RNF168 may account for the phenotypic deficits
associated with RNF17 inactivation. Noting the possibility
that the RNF17-UBE2U module may promote DDRs in both
RNF168-dependent and -independent manners, we decided
to evaluate the more immediate RNF168-dependent DSB
responses. We reasoned that if UBE2U or RNF17 promotes




































































































































FIGURE 3. UBE2U promotes cell responses to IR. A and B, U2OS cells trans-
fected with the indicated siRNAs were either left untreated or irradiated (2
Gy). Cells were fixed 1 h post-IR and immunolabeled with anti-H3-Ser(P)10
antibodies. Cells were subjected to flow cytometry-based analyses (A), and
means of three independent experiments are plotted (B). Error bars represent
S.D.C–E, U2OS cells were transfectedwith control siRNAs (siCTR) or those that
targeted RNF168 (siRNF168) or UBE2U (siUBE2U-1 and siUBE2U-2). Cells were
subsequently lysed and processed for Western blotting analysis using the
indicated antibodies (C), plated onto 60-mm dishes for the clonogenic sur-
vival assay (D), or processed as in A to determine the integrity of the G2/M
checkpoint (E). For the clonogenic survival assay, cells were allowed to
recover, and the number of colonies that formed after 14 days was counted.
Data represent themeanof three independent experiments, eachperformed
in triplicates. Error bars represent S.D.
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UBE2U- or RNF17-depleted cells one should restore 53BP1
IRIF. To this end, we transiently expressed RNF168 in UBE2U-
or RNF17-silenced cells and scored cells positive for 53BP1
focus formation after IR treatment. Most notably, although
depletion of RNF168, RNF17, and UBE2U impaired 53BP1
IRIF, re-expression of FLAG-tagged RNF168 efficiently allevi-
ated defective IRIF formation of 53BP1 in both UBE2U- and
RNF17-depleted cells (Fig. 6, G and H), indicating that reduc-
tion of RNF168 accounts for, at least in part, the defective DSB
responses seen with UBE2U and RNF17 deficiencies.
Discussion
Cell responses to DSBs entail a sophisticated ubiquitin-
driven DDR network (45). By utilizing an siRNA library
designed to target 37 known and predicted E2s, we systemat-
ically screened for a novel E2 that promotes chromatin
responses at DSBs and have successfully identified UBE2U as a
positive regulator of 53BP1 IRIF formation. Further mining of
the UBE2U interactome uncovered RNF17, among other can-
didate E3 ubiquitin ligases, as a novel regulator of DSB
responses. Together, our E2-guided screen approach not only
uncovered the UBE2U-RNF17 pair as a new E2-E3 module
important in drivingmammalianDDRs but also highlights how
such an approachmay be adaptable to studying and identifying
ubiquitin components in other biological processes.
A recent study showed that RNF17 might be involved in the
piRNA pathway (44). PIWI-interacting RNAs are a class of
small RNAs with length from 24 to 31 nucleotides. These small
RNAs interact with PIWI proteins to form an RNA-induced
silencing complex to repress transposons as well as other pro-
tein-coding genes. The PIWI-piRNA pathway has been exten-
sively studied in transposon silencing in germ lines. Although
the somatic function of PIWI proteins has been documented,
whether somatic piRNAs exist remains obscure (46, 47). Nota-
bly, RNF17 associates with PIWI (48) and was reported to sup-
press the biogenesis of secondary piRNAs (44). Consequently,
upon loss of RNF17, there was a700-fold increase in second-
ary piRNAs that mapped to protein-coding genes. Coinciden-
tally, one of these candidate targets included RNF168, suggest-
ing that RNF17 inactivation might trigger RNF168 gene
silencing through the piRNA pathway (44). Although the
mechanistic basis that details the RNF17-dependent regulation
of RNF168 expression remains to be defined, our observation
that silencing of RNF17 andUBE2U correlated with substantial
reduction in RNF168 mRNA and protein expression is in sup-
port of such a relationship. Because ectopically expressed
RNF168 restored 53BP1 IRIF in RNF17- and UBE2U-depleted
cells, we propose that the RNF17-UBE2U module promotes
DSB signal transduction, at least in part, via regulating RNF168
expression.
The E3 ubiquitin ligase RNF168 was originally identified as
the RIDDLE syndrome protein (1) where RNF168 deficiency






























































































FIGURE 4. Screen of UBE2U-interacting E3s identifies novel regulators of DSB responses. A, network illustration of interactions between UBE2U and its
potential E3 partners (35, 36). B and C, U2OS cells transfected with an E3-targeting siRNA library or the indicated siRNAs were irradiated (10 Gy). 4 h post-IR
treatment, cells were fixed, permeabilized, and immunostained with antibodies against 53BP1 and H2AX, and the percentage of 53BP1 focus-positive cells
(10 foci per cell) was quantified. Ranking by z score of all samples was plotted as described under “Experimental Procedures.” Representative images
following RNAi-mediated depletion of RNF17, TRIM34, TRIM65, or RNF10 are shown (C). Non-targeting siRNAs (siCTR) or RNF168-targeting siRNAs (siRNF168)
were used as negative and positive controls, respectively.
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signal transduction (2). As a key intermediate that propagates
DSB signals to orchestrate DDRs, RNF168 is also regulated by
many different factors to ensure that its function is executed
with spatiotemporal control. Indeed, although a number of
ubiquitin machineries, including TRIP12 and USP34, have
been reported to regulate RNF168 turnover (49–51), others
fine-tune RNF168 output by targeting its substrates (52–54).
Importantly, our identification of the UBE2U-RNF17 pair as
regulator of RNF168 expression represents an unprecedented
strategy to stringently keepRNF168 in check. Althoughwe can-
not exclude the possibility that RNF17 may also target other
components to effect DDRs because forced expression of
RNF168 restored 53BP1 IRIF in RNF17-depleted cells, we favor
a model in which RNF17, in concert with UBE2U, suppresses
secondary piRNA biogenesis to facilitate RNF168 expression
(Fig. 7). Together, these regulatory and proteolyticmechanisms
act to regulate RNF168 functions.
Although we envisage that RNF17-UBE2U encodes an
intrinsic RNF168 regulator, it is highly probable that the E3-E2
pair also regulates other cellular factors, especially given the
documented role of RNF17 in the piRNA pathway (44). Indeed,
although silencing of RNF17 or UBE2U led to partial reduction
of RNF168 expression, checkpoint control at the G2/M border
was consistently compromised to greater extents in cells
depleted of UBE2U. These data point to the exciting possibility
that the RNF17-UBE2U module may enforce DDRs in both
RNF168-dependent and -independent manners. Further work
will be necessary to comprehensively understand how the
RNF17-UBE2Upair regulatesmammalian cellular responses to
genotoxic stress.
AlthoughUBE2U remains to be characterized biochemically,
the fact that it associates with many E3 ubiquitin ligases points
to the possibility that it may serve as a catalytic activity in driv-





























































FIGURE 5. RNF17 is required for DSB retention of BRCA1 and 53BP1. A, schematic depicting the canonical DSB signal transduction pathway where the
RNF17-UBE2U pair may play a role at the RNF168 level (see text). B, UBE2U interacts with RNF17. 293T cells were transfected with constructs encoding
HA-UBE2U or streptavidin binding peptide-FLAG-tagged (Strep-FLAG) RNF17. Lysates were subjected to immunoprecipitation using streptavidin beads.
RNF17-co-purifying proteins were subjected to SDS-PAGE andWestern blotting analysis using the indicated antibodies. C–G, representative images showing
IR-induced focus formation of MDC1 and RNF8 (C), RNF168 and H2AX (D), 53BP1 (E), BRCA1 (F), or ubiquitin conjugates (FK2; G) following RNF17 silencing.
U2OS cells pretreated with RNF17-targeting siRNAs were irradiated (10 Gy) and processed for immunostaining experiments using the indicated antibodies.
Nuclei were visualized by DAPI staining. siRNA-mediated depletion of RNF8 or RNF168 was used as a positive control, and non-targeting siRNAs (siCTR) were
used as a negative control. The percentage of cells positive for IRIF is shown and represents the mean from at least two independent experiments (see
“Experimental Procedures”).
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multiple cancer-associated mutations have been identified on
the UBE2U coding sequence, in particular its UBC domain,
argues in favor of a critically important role of the E2 in cell
proliferation and homeostasis. Although we are beginning to
understand how the UBE2U-RNF17 pair may promote DSB
responses, much remains to be elucidated in the UBE2U biol-
ogy because a number of other putative UBE2U-interacting E3s
were also isolated in our E3 screen for their ability to promote
53BP1 IRIF formation. It would be of significant interest to
delineate precisely how the UBE2U network may have evolved
to innervate the DSB signal transduction pathways. In sum, our











































































































































































































FIGURE 6. RNF17 regulates RNF168 expression. A, schematic depicting RNF17 protein domain organization and the epitopes that are recognized by
anti-UBE2U antibodies. B and C, Proteintech or in-house anti-UBE2U antibodies specifically recognized ectopically expressed RNF17. D, validating RNAi-
mediated knockdown of RNF17. U2OS cells were co-transfectedwith FLAG-RNF17 and the indicated siRNAs. Cells were harvested, and lysates were separated
by SDS-PAGE.Western blotting experimentswere performed using the indicated antibodies. E, depletion of RNF17 or UBE2U down-regulated RNF168 protein
expression. U2OS cells were treated with the indicated siRNAs twice at 24-h intervals. 48 h after the second siRNA transfection, cells were lysed for Western
blotting analysis using the indicatedantibodies. F, RNF17orUBE2U silencing correlatedwith reduction inRNF168mRNA levels. Theexperimentwasperformed
as described under “Experimental Procedures.” RNAi-mediated knockdown of RNF168 was used as a positive control. G and H, ectopically expressed RNF168
restored 53BP1 IRIF in RNF17- and UBE2U-inactivated cells. Cells were depleted of RNF17 or UBE2U by the RNAi approach. 24 h after the second siRNA
transfection, cellswere transiently transfectedwith FLAG-taggedRNF168-expressing constructs or empty vector. 53BP1 IRIFwere analyzedby co-stainingwith
anti-FLAG antibodies 4 h after cell exposure to 10 Gy IR. Representative images are shown (G). The percentage of cells positive for 53BP1 IRIF following
reintroduction of RNF168 is plotted (H). As a control, 53BP1 IRIF-positive cells were scored when foci numbered 10 per nuclei following RNAi. For FLAG-
RNF168 re-expression experiments, 53BP1 IRIFwere scored only in FLAG-positive cells. Results represent themean of three independent experiments. At least
100 nuclei were counted each time. Arrows indicate cells that ectopically express Flag-RNF168. Error bars represent S.D. *, p 0.05; **, p 0.01; ***, p 0.001;
****, p 0.0001 versus control. siCTR, control siRNAs.
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DSB signal transduction events has uncovered a list of novel
ubiquitin components and highlights the important regulatory
role of ubiquitin machineries in genome integrity protection.
Experimental Procedures
Cell Culture—U2OS, 293T, and HeLa cell lines from ATCC
were cultured inDulbecco’smodified Eagle’smedium (DMEM)
supplemented with 10% fetal bovine serum (FBS) at 37 °C in 5%
CO2.
Plasmids and siRNAs—The expression construct of FLAG
epitope-tagged RNF168was described previously (4). For RNAi
experiments, cells were transfected twice with target siRNAs
(Dharmacon) using Oligofectamine according to the manufa-














































































































































































FIGURE 7. Working model depicting the role of UBE2U and RNF17 in
RNF168-dependent DSB responses. A, RNF17 and UBE2U may suppress
biogenesis of secondary piRNAs. RNF168 is expressed and catalyzes chroma-
tin ubiquitylation at DSBs to assemble 53BP1 and BRCA1. B, silencing of
RNF17 or UBE2U leads to down-regulation of RNF168 expression. Ubiquitin-
mediatedDSB signals are not propagated, and cells donot efficiently support
53BP1 and BRCA1 IRIF. siCTR, control siRNAs.
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ing 37 E2s and 64 UBE2U-interacting E3s were purchased from
GenePharma (Table 1). siRNAs for cell depletion of UBC13,
RNF8, and RNF168 were described previously (31, 56).
Sequences for siRNAs that target UBE2U were as follows:
siUBE2U-1,5-GCUCCUCCAGUUGUGAAAUTT-3; siUBE2U-2,
5-GCCACAGAAUACUACAGAATT-3. Sequences of siRNAs
that targeted RNF17 were as follows: siRNF17-1, 5-GAGGA-
ACAAUGGGAAAUAATT-3; siRNF17-2, 5-GAACAU-
AGCAAGAGCAUUAUU-3.
Antibodies—Antibodies againstH2AX, FK2,UBC13, RNF8,
RNF168, andMDC1were described previously (4, 31, 57). Anti-
FLAG (M2) and anti-actin were from Sigma. Anti-BRCA1 (D9)
was purchased from Santa Cruz Biotechnology. Anti-HA anti-
bodies were from Covance. The phosphospecific antibody
against histone H3-Ser(P)10 was purchased from Cell Signaling
Technology. Anti-KAP1 was from BD Biosciences.
Immunofluorescence Staining—To detect IRIF, cells were
irradiated (10 Gy) 48 h post-siRNA transfection. Cells were
subsequently fixed with 3% paraformaldehyde at room temper-
ature for 15 min. Permeabilization was performed using 0.5%
Triton X-100 solution for 1 min prior to standard immuno-
staining procedures. Images were acquired using an Olympus
BX51 fluorescence microscope. The number of 53BP1 foci per
cell was counted using Imaris software.
G2/M Checkpoint Assay—U2OS cells were treated with the
indicated siRNAs twice and subjected to IR treatment (2 Gy) or
left untreated. 1 h post-IR, cells were trypsinized and fixed with
70% ice-cold ethanol. To analyze the mitotic cell population,
cells were stained with primary antibody against histone
H3-Ser(P)10 followed by incubationwith FITC-conjugated goat
anti-rabbit antibodies (Jackson ImmunoResearch Laborato-
ries). DNA content was measured by propidium iodide stain-
ing, and percentage of histone H3-Ser(P)10-positive cells was
determined by flow cytometric analysis on a BD Biosciences
LSR Fortessa analyzer.
RNA Isolation and Real Time PCR Analyses—U2OS cells
were treated with the indicated siRNAs twice. 48 h after the
second transfection, cells were collected by trypsinization.
Total RNA was isolated using TRIzol reagent (Invitrogen, Life
Technologies) following themanufacturer’s protocol. The con-
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2000 (Thermo Scientific) and agarose gel electrophoresis,
respectively. 1 g of RNA for each sample was reverse tran-
scribed into cDNA using SuperScript II reverse transcriptase
(Invitrogen, Life Technologies) following the manufacturer’s
protocol. Expression of RNF168 mRNAs was determined by
real time PCR. cDNA samples were amplified using iQTM
SYBR Green Supermix on a Bio-Rad iQ5 following the man-
ufacturer’s protocol. Results were derived from three indepen-
dent experiments, each performed in triplicates. Real time PCR
primers for RNF168 and GAPDH (control) were as follows:
RNF168 RT1-forward, 5-AATCTCAGTTTGGGTCAGCC-
3; RNF168 RT1-reverse, 5-TGGAGAAAGTGTCGGCAT-
ATC-3; RNF168 RT2-forward, 5-AGTTCGTCTGCTCAGT-




Clonogenic Survival Assay—U2OS cells were transfected
with siRNAs against UBE2U or RNF168 or control siRNA
twice. 48 h after the second transfection, 500 cells were plated
onto 60-mm dishes and treated with different dosages of IR.
Cells were allowed to grow for 14 days and subjected to Coo-
massie Brilliant Blue staining before colony counting.
Author Contributions—M. S. Y. H. and S. M. H. S. conceptualized
and supervised the project. Y. G. and L. A. performed all the experi-
ments with help from H.-M. N. and S. M. H. S. M. S. Y. H.,
S. M. H. S., and Y. G. analyzed the data. Y. G. andM. S. Y. H. drafted
the manuscript. H.-M. N. designed the schematic illustration. All
authors reviewed the results and approved the final version of the
manuscript.
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